merk-m-logo-blue

Meet HUB Organoids
at AACR Annual
Meeting 2025

Booth #1560

April 25 - 30, 2025
McCormick Place Convention Center
Chicago, IL

Request a meeting

Advancing Oncology Drug Development with Patient-Derived Organoids

Join HUB Organoids at AACR 2025, where we will be showcasing cutting-edge research on patient-derived organoid models as transformative tools for oncology drug development. Our posters highlight the latest advancements in ADC efficacy assessment, KRAS inhibitor screening, and mechanisms of drug tolerance, demonstrating the power of organoids in modeling patient-specific treatment responses. Additionally, we present a comparative analysis of ATP-based vs. image-based viability readouts, providing insights into optimizing in vitro drug screening. Visit our posters to explore how HUB Organoids’ platforms enhance preclinical precision oncology and accelerate the development of targeted cancer therapies.

Discover our Science

30 April 2025
listing-img
POSTER PRESENTATION

Patient-derived organoids: an in vitro platform for evaluating ADC efficacy, potency, and specificity

Abstract #6743, Presented on 30 April 2025 at 9:00AM - 12:00PM
29 April 2025
listing-img
POSTER PRESENTATION

Comparing ATP-Based and Image-Based Viability Readouts for Assessing Treatment Responses in Patient-Derived Organoids

Abstract #3994, Presented on 29 April 2025 at 9:00AM - 12:00PM
listing-img
POSTER PRESENTATION

A patient-derived organoid screening platform as a powerful tool to study efficacy of KRAS inhibitors

Abstract #5706, Presented on 29 April 2025 at 2:00PM - 5:00PM
listing-img
POSTER PRESENTATION

From persistence to resistance: Insights into the mechanisms of drug tolerance in cancer therapy using patient-derived organoids

Abstract #5551, Presented on 29 April 2025 at 2:00PM - 5:00PM
request a meeting